C A Uyl-de Groot - JoVE Visualize

Showing results (41-50 of 67) with videos related to

Pageof 7

Sort By:

European Journal of Cancer (Oxford, England : 1990)|March 10, 1999

Cost of care in a randomised trial of early hospital discharge after surgery for breast cancerJ Bonnema, A M van Wersch, A N van Geel, et al.

ESMO Open|November 15, 2021

Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluationE E A P Mulder, L Smit, D J Grünhagen, et al.

BMC Cancer|June 12, 2016

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registryS De Groot, S Sleijfer, W K Redekop, et al.

European Journal of Cancer (Oxford, England : 1990)|October 26, 2001

The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-upM van Agthoven, B M van Ineveld, M F de Boer, et al.

European Journal of Cancer Care|December 31, 2013

Real-world resource use and costs of adjuvant treatment for stage III colon cancerC W M van Gils, S de Groot, S S Tan, et al.

Bone Marrow Transplantation|April 1, 1995

Costs of introducing autologous BMT in the treatment of lymphoma and acute leukaemia in The NetherlandsC A Uyl-de Groot, S Y Okhuijsen, A Hagenbeek, et al.

Plos One|February 1, 2024

Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumabR J S D Heine, F W Thielen, R H J Mathijssen, et al.

BMC Cancer|November 22, 2018

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trialA van Ommen-Nijhof, I R Konings, C J J van Zeijl, et al.

European Journal of Haematology|November 15, 2002

Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphomaM van Agthoven, L M Faber, C A Uyl-de Groot, et al.

Vaccine|March 10, 2005

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefitsC A Uyl-de Groot, J B Vermorken, M G Hanna, et al.

Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:

Pageof 7

European Journal of Cancer (Oxford, England : 1990)|March 10, 1999

Cost of care in a randomised trial of early hospital discharge after surgery for breast cancerJ Bonnema, A M van Wersch, A N van Geel, et al.

ESMO Open|November 15, 2021

Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluationE E A P Mulder, L Smit, D J Grünhagen, et al.

BMC Cancer|June 12, 2016

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registryS De Groot, S Sleijfer, W K Redekop, et al.

European Journal of Cancer (Oxford, England : 1990)|October 26, 2001

The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-upM van Agthoven, B M van Ineveld, M F de Boer, et al.

European Journal of Cancer Care|December 31, 2013

Real-world resource use and costs of adjuvant treatment for stage III colon cancerC W M van Gils, S de Groot, S S Tan, et al.

Bone Marrow Transplantation|April 1, 1995

Costs of introducing autologous BMT in the treatment of lymphoma and acute leukaemia in The NetherlandsC A Uyl-de Groot, S Y Okhuijsen, A Hagenbeek, et al.

Plos One|February 1, 2024

Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumabR J S D Heine, F W Thielen, R H J Mathijssen, et al.

BMC Cancer|November 22, 2018

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trialA van Ommen-Nijhof, I R Konings, C J J van Zeijl, et al.

European Journal of Haematology|November 15, 2002

Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphomaM van Agthoven, L M Faber, C A Uyl-de Groot, et al.

Vaccine|March 10, 2005

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefitsC A Uyl-de Groot, J B Vermorken, M G Hanna, et al.

Pageof 7